Real-time enrollment status for this participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:16 PM UTC
| NCT Number | NCT05822427 |
| Recruiting Status | Recruiting |
| Condition | Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Imugene Limited |
| Last Updated on CT.gov | May 14, 2025 (May 14, 2025) |
As of July 13, 2026: Clinical trial NCT05822427 is currently recruiting participants. This clinical trial study for participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study is actively seeking new participants at 1 location across the United States. The study is sponsored by Imugene Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05822427 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05822427 was last updated May 14, 2025 (May 14, 2025). HelloStudys verifies this status automatically.